A 28 year old man with primary hypoparathyroidism failed to respond to treatment with calcium and vitamin D analogues. Despite extensive investigation no reason for this was found and he is now successfully treated with teriparatide (synthetic human PTH)
Get full access to this article
View all access options for this article.
References
1.
NeerRM, TregearGW, PottsJTJr. Renal effects of native parathyroid hormone and synthetic biologically active fragment in pseudohypoparathyroidism and hypoparathyroidism. Journal of Clinical Endocrinology and Metabolism.44(2):420–3, 1977 Feb
2.
McElduffA, LissnerD, WilkinsonM, CornishC, PosenS.A 6-hour human parathyroid hormone infusion protocol: studies in normal and hypoparathyroid subjects. Calcified Tissue International41 (5) 267–73. 1987 Nov
3.
WinerKK., KoCW., ReynoldsJC., DowdyK., KeilM., PetersonD., GerberLH., McGarveyC., CutlerGBJr. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. [Clinical Trial. Journal Article. Randomized Controlled Trial]Journal of Clinical Endocrinology & Metabolism.88(9): 4214–20, 2003 Sep.
4.
WinerKK, YanovskiJA, CutlerGBJr. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA.276(8): 631–6. 1996 Aug
